R
Cartesian Therapeutics, Inc.
RNAC · NASDAQ · Healthcare · 260M
Closing price
$7.05
+3.45% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-0.5×
Free cash flow yieldFCF yield
-43.3%
Return on equityROE
103.2%
Operating margin
-3099.9%
Net debt / EBITDAbalance-sheet strength
0.8×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.